RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Midatech Pharma Stock

Midatech Pharma Net Income 2024

Midatech Pharma Net Income

-5.46 M GBP

Ticker

MTPH.L

ISIN

GB00BKT14T00

In 2024, Midatech Pharma's profit amounted to -5.46 M GBP, a -75.39% increase from the -22.19 M GBP profit recorded in the previous year.

The Midatech Pharma Net Income history

YEARNET INCOME (undefined GBP)
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-

Midatech Pharma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Midatech Pharma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Midatech Pharma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Midatech Pharma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Midatech Pharma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Midatech Pharma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Midatech Pharma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Midatech Pharma’s growth potential.

Midatech Pharma Revenue, EBIT and net profit per share

DateMidatech Pharma RevenueMidatech Pharma EBITMidatech Pharma Net Income
2021578,000 GBP-7 M GBP-5.46 M GBP
2020343,000 GBP-10.67 M GBP-22.19 M GBP
2019674,000 GBP-11.32 M GBP-10.09 M GBP
20181.94 M GBP-11.82 M GBP-15.03 M GBP
2017989,000 GBP-11.78 M GBP-16.06 M GBP
20161.32 M GBP-9.65 M GBP-20.16 M GBP
20151.38 M GBP-9.93 M GBP-10.1 M GBP
2014157,000 GBP-9.69 M GBP-8.82 M GBP
2013150,000 GBP-4.5 M GBP-4.08 M GBP
2012280,000 GBP-6.24 M GBP-6.12 M GBP
2011310,000 GBP-5.74 M GBP-5.74 M GBP

Midatech Pharma stock margins

The Midatech Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Midatech Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Midatech Pharma.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Midatech Pharma's sales revenue. A higher gross margin percentage indicates that the Midatech Pharma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Midatech Pharma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Midatech Pharma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Midatech Pharma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Midatech Pharma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Midatech Pharma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Midatech Pharma Margin History

Midatech Pharma Gross marginMidatech Pharma Profit marginMidatech Pharma EBIT marginMidatech Pharma Profit margin
202194.91 %-1,210.73 %-944.64 %
202094.91 %-3,111.08 %-6,469.1 %
201994.91 %-1,679.23 %-1,496.29 %
201894.91 %-609.65 %-775.54 %
201794.91 %-1,190.7 %-1,624.27 %
201694.91 %-729.55 %-1,523.96 %
201594.91 %-721.96 %-734.47 %
201494.91 %-6,170.06 %-5,619.11 %
201394.91 %-3,000 %-2,720 %
201294.91 %-2,228.57 %-2,185.71 %
201194.91 %-1,851.61 %-1,851.61 %

Midatech Pharma Aktienanalyse

What does Midatech Pharma do?

Midatech Pharma is an international biotechnology company specializing in the development and commercialization of innovative therapeutic products based on nanotechnology. The company was founded in 2000 and is headquartered in the UK. Its business model focuses on identifying disease areas with high medical needs and limited availability of effective therapies. By using nanoparticles, drugs are targeted to specific cells or tissue areas, increasing efficacy while minimizing side effects. Midatech Pharma has specialized in researching and developing products for rare diseases and cancer, with three business divisions: Midatech Pharma US, Midatech Pharma Europe, and Midatech Pharma Asia. Midatech Pharma US, located in Philadelphia, focuses on developing drugs for rare diseases, particularly for neurological disorders such as brain tumors and epilepsy. It has already received approvals for two novel drugs, including a spray for acute epilepsy seizures and a nasal spray formulation for treating carcinoid tumors. Midatech Pharma Europe, based in Bilbao, Spain, specializes in manufacturing and developing drugs for cancer, including innovative nanotechnology-based therapies for prostate cancer, pancreatic cancer, and hepatocellular carcinoma. The company has conducted several clinical studies in Europe and the US, including successful phase II trials for a drug treating pancreatic cancer. Midatech Pharma Asia, located in China, focuses on developing and marketing drugs for the Asian market, collaborating closely with local partners to establish a comprehensive distribution network. The company has already introduced several drugs for cancer and other diseases to the Asian market. Key products of Midatech Pharma include MTX110, an innovative drug for treating DIPG (diffuse intrinsic pontine glioma); MTX102, a nasal spray for treating benign carcinoid tumors; and MTX225, a novel drug formulation for treating prostate cancer. Overall, Midatech Pharma has established itself as a leading company in the field of nanotechnology-based drug development in recent years. With its focus on rare diseases and the synergy of innovation and market proximity, the company is well positioned for future success. Midatech Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Midatech Pharma's Profit Margins

The profit margins of Midatech Pharma represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Midatech Pharma's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Midatech Pharma's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Midatech Pharma's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Midatech Pharma’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Midatech Pharma stock

How much profit has Midatech Pharma made this year?

Midatech Pharma has made -5.46 M GBP this year.

How has the profit developed compared to last year?

The profit has increased by -75.39% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Midatech Pharma publish its earnings?

Midatech Pharma publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Midatech Pharma?

The profits of Midatech Pharma are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Midatech Pharma?

You can learn more about the earnings of Midatech Pharma by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Midatech Pharma pay?

Over the past 12 months, Midatech Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Midatech Pharma is expected to pay a dividend of 0 GBP.

What is the dividend yield of Midatech Pharma?

The current dividend yield of Midatech Pharma is .

When does Midatech Pharma pay dividends?

Midatech Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Midatech Pharma?

Midatech Pharma paid dividends every year for the past 0 years.

What is the dividend of Midatech Pharma?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Midatech Pharma located?

Midatech Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Midatech Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Midatech Pharma from 11/4/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Midatech Pharma pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Midatech Pharma in the year 2023?

In the year 2023, Midatech Pharma distributed 0 GBP as dividends.

In which currency does Midatech Pharma pay out the dividend?

The dividends of Midatech Pharma are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Midatech Pharma

Our stock analysis for Midatech Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Midatech Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.